Nanoparticle Generator Slips Chemotherapy Past Tumor Cells’ Protective Barriers

Researchers have developed a new injectable nanoparticle-generating technology that can deliver a cancer drug to the nucleus of metastatic breast...

most common investor mistakes

Mistakes Most Investors Make

Mistakes Most Investors Make Top 3 Mistakes Most Investors Make Over the years investors have been convinced that proper investing...

FDA Approves Three Immunotherapy Drugs for Patients with Bladder Cancer

The FDA has approved three immunotherapy drugs—avelumab, atezolizumab, and durvalumab—for the treatment of patients with bladder cancer. All three drugs...

Toward Precision Therapy for Children with Cancer: An Interview with Dr. Javed Khan

NCI’s Dr. Javed Khan discusses a new NCI clinical program and the promise and challenges of genome-guided therapy for children...

Vitamin D Deficiency May Promote Spread of Some Breast Cancers

Low vitamin D levels are associated with metastasis in women with breast cancer, suggests a new study. Source link

Pembrolizumab Shows Promise in Patients with Rare Form of Skin Cancer

In a small clinical trial, more than half of the patients with an aggressive form of skin cancer called Merkel...

A Shared Commitment for Accelerating Progress with the Cancer Moonshot

At the AACR annual meeting, Vice President Biden spoke about the National Cancer Moonshot Initiative and the critical role the...

New Treatment Target Identified for Key Prostate Cancer Driver

Researchers have identified a potential alternative approach to blocking a key molecular driver of an advanced form of prostate cancer,...

Targeted Photoimmunotherapy Approach for Cancer Moves Forward

Two new studies from NCI researchers add to growing evidence of the promise of a novel type of cancer immunotherapy...